Below are the best information and knowledge on the subject treatment for frequent pvcs compiled and compiled by our own team alltopus:
1. Clinical Approach to Patients with Frequent PVCs | Sarver Heart Center
Date Submitted: 04/17/2021 03:32 AM
Average star voting: 4 ⭐ ( 46210 reviews)
Summary: Premature ventricular complexes, or PVCs, are a common clinical problem. While patients may be asymptomatic, typically these PVCs cause sensations of skipping, heart pounding, and possibly chest pain, shortness of breath or dizziness.
Match with the search results: Beta blockers are safe and effective drugs that are often used to treat heart arrhythmias. Other drugs that may be used to treat frequent PVCs include …. read more
2. Frequent ventricular extrasystoles: significance, prognosis and treatment
Date Submitted: 05/01/2020 11:11 AM
Average star voting: 4 ⭐ ( 52938 reviews)
Summary: Your access to the latest cardiovascular news, science, tools and resources.
Match with the search results: Those used for PVCs may include beta blockers and calcium channel blockers. Drugs to control the heart rhythm also may be prescribed if you have ……. read more
3. Treatment of Premature Ventricular Complexes
Date Submitted: 03/16/2021 03:54 AM
Average star voting: 4 ⭐ ( 37904 reviews)
Summary: The treatment of premature ventricular complexes, or PVCs, depends on the symptoms they are causing and on any associated underlying heart disease.
Match with the search results: Patients with significant and/or persistent PVC-related symptoms should be treated to reduce the PVC burden. Most commonly we begin medical ……. read more
4. Clinical Significance of Idiopathic Frequent Premature Ventricular Complexes | USC Journal
Date Submitted: 06/11/2020 03:15 PM
Average star voting: 4 ⭐ ( 51001 reviews)
Match with the search results: Patients with frequent symptomatic PVCs with underlying heart failure benefit from beta blockade regardless of the etiology of the cardiomyopathy. Carvedilol, ……. read more
5. Premature ventricular contractions (PVCs)
Date Submitted: 06/21/2021 08:46 AM
Average star voting: 3 ⭐ ( 81773 reviews)
Summary: OverviewPremature ventricular contractions (PVCs) are extra heartbeats that begin in one of the heart’s two lower pumping chambers (ventricles). These extra beats disrupt the regular heart rhythm, sometimes causing a sensation of a fluttering or a skipped beat in the chest.
Match with the search results: Patients with a high frequency of PVC (> 20-40% of all beats) may require more aggressive therapy independent of symptoms. There have been some reports of ……. read more
6. Premature Ventricular Contractions: PVC Treatments & Symptoms
Date Submitted: 05/16/2021 01:43 PM
Average star voting: 5 ⭐ ( 14920 reviews)
Summary: Premature ventricular contractions are a relatively common type of arrhythmia in adults and children. Learn more about PVC treatments, PVC symptoms & PVC causes.
Match with the search results: B-blockers are usually very effective. Radiofrequency catheter ablation therapy has generally been reserved for patients with frequent PVCs ……. read more
7. The safety of catheter ablation for premature ventricular contractions in patients without structural heart disease – BMC Cardiovascular Disorders
Date Submitted: 04/07/2020 08:08 PM
Average star voting: 5 ⭐ ( 56863 reviews)
Summary: Patients with frequent premature ventricular contractions (PVCs) are often symptomatic. Catheter ablation was usually indicated to eliminate symptoms in patients with PVCs-induced cardiomyopathy. Currently, PVCs-ablation is also applied for patients with PVCs and no structural heart diseases (SHD); however, the safety and efficacy of ablation in these patients remains unclear. In this retrospective study, data from patients who underwent ablation for PVCs from January 2010 to December 2016 at our hospital was retrieved. Predictors of complications and acute procedural success were evaluated. A total of 1231 patients (mean age 47.8 ± 16.8 years, 59% female) were included. The overall complication rate was 2.7%, and the most common complication was hydropericardium. Two ablation-related mortalities occurred. One patient died of coronary artery injury during the procedure and the other died from infectious endocarditis. Location (left ventricle and epicardium) was the main predictor of complications, with right ventricular outflow tract (RVOT) predicting fewer complications. The acute procedural success rate was 94.1% in all patients. The main predictor of acute procedural success was RVOT origin, while an epicardial origin was a predictor of procedural failure. Locations of left ventricle and epicardium were predictors of procedural complications for patients with PVCs. Therefore, ablation is not recommended in these patients. For other origins of PVCs, particularly RVOT origin, ablation is a safety and effective treatment.
Match with the search results: Catheter ablative therapy has a role in the management of patients with PVCs. … This is in the setting of PVCs from the right or left ……. read more
8. Effect of carvedilol on premature ventricular complexes originating from the ventricular outflow tract – International Journal of Arrhythmia
Date Submitted: 05/28/2021 10:23 PM
Average star voting: 5 ⭐ ( 27680 reviews)
Summary: Carvedilol is one of the most effective beta-blockers in reducing ventricular tachyarrhythmias and mortality in patients with heart failure. One of the possible antiarrhythmic mechanisms of carvedilol is the suppression of store overload-induced Ca2+ release, especially for the triggered activity. Premature ventricular complex (PVC) originating from the ventricular outflow tract (OT) is the most common form of idiopathic PVC, and its main mechanism is related to triggered activity. We evaluate the efficacy of carvedilol to suppress the OT PVC. The electronic medical records at our hospital were screened to identify OT PVC patients treated with carvedilol. Clinical, electrocardiographic, and Holter monitoring studies were reviewed. A total of 25 patients who underwent Holter monitoring before and after carvedilol administration were found and enrolled. The mean age of the patients was 54.9 ± 13.9 years, and the mean dose of carvedilol was 18.2 ± 10.2 mg (sustained release formulation, 8/16/32 mg). The 24-h burden of PVC in 18 (72%) of 25 patients was significantly reduced from 12.2 ± 9.7% to 4.4 ± 6.7% (P = 0.006). In seven patients, the burden of PVC was changed from 7.1 ± 6.1% to 9.8 ± 8.4% (P = 0.061). There was no difference in age, carvedilol dose, duration of treatment, ventricular function, and left atrial size between responding and non-responding groups. In this retrospective pilot study, treatment with carvedilol showed PVC suppression in 72% of patients. Now, we are conducting a prospective, randomized, multicenter study to evaluate the effect of carvedilol on OT PVC (Clinical trial registration: FOREVER trial, Clinical-Trials.gov: NCT03587558).
Match with the search results: Treatment for patients who experience PVCs on a regular basis includes medication such as beta blockers and calcium blockers. For patients whose symptoms are ……. read more
9. An observational study on the effect of premature ventricula… : Medicine
Date Submitted: 02/11/2021 05:57 PM
Average star voting: 5 ⭐ ( 28274 reviews)
Match with the search results: OHSU Knight Cardiovascular Institute. Treating persistent PVCs. Using radiofrequency catheter ablation to treat premature ventricular complexes ……. read more
10. The Ubiquitous Premature Ventricular Complex
Date Submitted: 12/03/2020 12:48 AM
Average star voting: 4 ⭐ ( 94993 reviews)
Summary: Premature ventricular complexes (PVCs) are one of the most commonly encountered arrhythmias and are ubiquitous in clinical practice, both in the outpatient and inpatient settings. They are often discovered incidentally in asymptomatic patients, however, can cause myriad symptoms acutely and chronically. Long thought to be completely benign, PVCs have been historically disregarded without pursuing any further evaluation. Newer data have revealed that a high burden of PVCs with specific characteristics can significantly increase a patient’s risk of developing PVC-induced cardiomyopathy. The aim of this literature review is to provide further clarification on the identification of high-risk PVCs, subsequent workup, and the currently available treatment options. PVCs arise from an ectopic focus within the ventricles. Patients with PVCs can be either asymptomatic or have severe disabling symptoms. The diagnostic workup for PVCs includes electrocardiogram (ECG) and 24-h Holter monitor to assess the QRS morphology and its frequency. A transthoracic echocardiogram (TTE) is done to look for structural heart disease and cardiomyopathy. Management of PVCs should be focused on identifying and treating the underlying causes, such as electrolyte abnormalities, substance use, and underlying structural heart disease. Beta-blockers are first-line therapy for symptomatic PVCs. Nondihydropyridine calcium channel blockers, classic antiarrhythmic agents, and amiodarone can be considered as second-line agents. Patients who are unable to tolerate medical therapy should undergo catheter ablation of the PVC focus to prevent PVC-induced cardiomyopathy. PVCs are common in clinical practice, and it is vital to identify patients at higher risk for PVC-induced cardiomyopathy to facilitate early intervention. Patients with no evidence of structural heart disease and infrequent PVCs should be monitored closely, while those who are symptomatic should be treated medically. For those who have failed medical therapy, catheter ablation of the PVCs focus is recommended. Catheter ablation has been shown to reduce PVCs burden and improve left ventricular ejection fraction (LVEF) in those with PVC-induced cardiomyopathy.
Match with the search results: You probably don’t need medical treatment for PVCs if they don’t happen often and you don’t have other health conditions….. read more